Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Data Driven Bioscience
AddedFeb 15, 2024
UpdatedJun 18, 2026
Data Driven Bioscience

Data Driven Bioscience

Seed

Data-driven biotech firm providing genomic tools for cancer diagnosis and treatment in clinical labs.

HQ
Durham, NC, US
Founded
2018
Accelerator
Y Combinator logoY CombinatorS18
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize cancer diagnosis and treatment, Data Driven Bioscience is a biotechnology company that provides advanced genomic tools to clinical laboratories. Their core vision is to harness the power of genomics to improve patient outcomes by enabling personalized therapy. The company's primary product, DuoSeq, facilitates the molecular identification of responders in clinical trials, thereby enhancing the precision and effectiveness of cancer treatments.

Data Driven Bioscience has garnered attention for its innovative approach to genomics in clinical settings. The company collaborates with leading researchers and clinicians to integrate their tools into practice, significantly impacting cancer treatment protocols. Notable investors and affiliations include prominent biotech venture capital firms and academic institutions. Their achievements include successful implementation of their genomic tools in multiple clinical trials, demonstrating a tangible improvement in patient response rates and reducing adverse events.

Data Driven Bioscience - Quick Facts

When was Data Driven Bioscience founded?

Data Driven Bioscience was founded in 2018.

Where is Data Driven Bioscience's headquarters located?

Data Driven Bioscience's headquarters is located in Durham, NC, US.

When was Data Driven Bioscience's last funding round?

Data Driven Bioscience's most recent funding round was for $120k (USD) in August 2018.

How much has Data Driven Bioscience raised to-date?

As of Aug 20, 2018, Data Driven Bioscience has raised a total of $120k (USD).

How many employees does Data Driven Bioscience have?

Data Driven Bioscience has 30 employees as of Feb 4, 2024.

Data Driven Bioscience - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
  • Genomics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Genomic Tools
Tags
  • Data Information
  • Healthcare
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software